Evidence map›Paper›PMID 24176420›Full record

ReviewNeurologic clinics2013

Clinical neurogenetics: autosomal dominant spinocerebellar ataxia.

Vikram G Shakkottai, Brent L Fogel

Open access · greenAbstract readReview
In one paragraph

Review in Neurologic clinics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 84 citations in OpenAlex.

  1. Trial
  2. Monoallelic ATP7B variants in adult-onset cerebellar ataxia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Eye movement changes in autosomal dominant spinocerebellar ataxias.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Vikram G ShakkottaiDepartment of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. Electronic address: vikramsh@med.umich.edu.
Brent L Fogel
University of California, Los Angeles · USUniversity of Michigan–Ann Arbor · US

Funding

Targeting physiologic changes as a route towards therapy for degenerative ataxiasK08NS072158 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI SHAKKOTTAI, VIKRAM GOVINDARAJU · 2010 to 2014
$885k
The Role of Fox-1 in Neurodevelopment and Autistic Spectrum DisorderK08MH086297 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FOGEL, BRENT LINDEN · 2009 to 2013
$719k
NIMH NIH HHS K08 MH086297NIMH NIH HHS K08MH086297NINDS NIH HHS K08 NS072158NINDS NIH HHS K08NS072158
6 · The paper itself

Abstract

The autosomal dominant spinocerebellar ataxias are a diverse and clinically heterogeneous group of disorders characterized by degeneration and dysfunction of the cerebellum and its associated pathways. Clinical and diagnostic evaluation can be challenging because of phenotypic overlap among causes, and a stratified and systematic approach is essential. Recent advances include the identification of additional genes causing dominant genetic ataxia, a better understanding of cellular pathogenesis in several disorders, the generation of new disease models that may stimulate development of new therapies, and the use of new DNA sequencing technologies, including whole-exome sequencing, to improve diagnosis.

Indexed as

Genetic TestingAnimalsDisease Models, AnimalHumansMachado-Joseph DiseaseMicePeptidesRatsSpinocerebellar AtaxiasPeptidespolyglutamineAtaxiaAutosomal dominantCerebellumSCASpinocerebellar

Identifiers

PMID24176420
PMCPMC3818725
OpenAlexW87918927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.